Pear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAP

Alcohol is the most common substance use disorder (SUD), representing 70% of the more than 40 million people with SUD1 New data from real-world use of reSET® demonstrate patients who use alcohol exhibit robust engagement, retention, and abstinence BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital […]


Go to Source

Powered by WPeMatico